Samuraciclib hydrochloride
Product Specifications
CAS Number
1805789-54-1
Target
Apoptosis|||CDK
Related Pathways
Cell Cycle/Checkpoint|||Apoptosis
Purity
0.998
Bioactivity
Samuraciclib hydrochloride (ICEC0942 hydrochloride) is a potent, selective, ATP competitive and oral active CDK7 inhibitor with IC50 of 41 nM. The selectivity of Samuraciclib hydrochloride is 45-, 15-, 230- and 30-fold higher than CDK1, CDK2 (IC50 is 578 nM), CDK5 and CDK9 respectively. Samuraciclib hydrochloride inhibits the growth of breast cancer cell lines with GI50 values between 0.2-0.3 ?M. Samuraciclib hydrochloride has anti-tumor effects.
Smiles
Cl.CC(C)c1cnn2c(NCc3ccccc3)cc(NC[C@H]3CCNC[C@@H]3O)nc12
Molecular Formula
C22H31ClN6O
Molecular Weight
430.97
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
SPT01215 10 Gels/Pack
Super-Gel Plastic 12% Tris-Gly Precast PAGE (15 Wells, 1.0mm)
Ask
View Details 032796-FITC 200 µL
C19orf39, ID (SWSAP1, C19orf39, ATPase SWSAP1, SWIM-type zinc finger 7-associated protein 1, SWS1-associated protein 1, ZSWIM7-associated protein 1) (FITC) discontinued
Ask
View Details 
